share_log

港股异动 | 平安健康(01833)涨超8% AI科技运营赋能医生效率提升 公司医疗和健康服务毛利率双双提升

Changes in Hong Kong stocks | Ping An Health (01833) rose more than 8% AI technology operation empowers doctors to improve efficiency and increase the company's gross margin of medical and health services

Zhitong Finance ·  Mar 20 21:58

Ping An Health (01833) rose more than 8% and rose 8.29% at press time to HK$13.32, with a turnover of HK$35.44 million.

The Zhitong Finance App learned that Ping An Health (01833) rose by more than 8% and rose 8.29% at press time to HK$13.32, with a turnover of HK$35.44 million.

According to the news, the company previously announced audited annual results for the year ended December 31, 2023. The group achieved revenue of 4.674 billion yuan (RMB, same below) and gross profit of 1,509 billion yuan during the period. During the reporting period, the company's strategic business (i.e. medical and health care services, the same as later) grew strongly. With the completion of basic adjustments to the company's low strategic synergy business, the company further focused resources on strategic business development. The company obtained F-side strategic business revenue (that is, F-side healthcare service revenue, same) of 2.205 billion yuan, a year-on-year increase of 14.8% (2022:1,921 billion yuan), and B-side strategic business revenue (referring to enterprise health business, B-side healthcare services, same later) of 1,079 million yuan, an increase of 81.2% (2022:595 million yuan).

Furthermore, with the strengthening of strategic business cost management, AI technology operations enabled physicians to improve efficiency, and the gross margin of the company's medical and health services both increased. Among them, the gross margin of medical services increased from 35% in 2022 to 40% in 2023, and the gross margin of health services increased from 21.1% to 26.1%. The increase in gross margin of the medical and health sector and the optimization of the revenue structure contributed to a year-on-year increase of 5.4 pct in the company's overall gross margin to 32.3%. Li Dou, chairman of the company's board of directors, said that for the company, AI is a position to assist doctors in diagnosis and treatment. The company will continue to improve the capabilities of the big model and further explore the field from service to serious medical care.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment